Intermittent treatment with parathyroid hormone (PTH) as well as a non-peptide small molecule agonist of the PTH1 receptor inhibits adipocyte differentiation in human bone marrow stromal cells

Bone

Volumn 39, Issue 6, 2006, Pages 1361-1372

  Rickard, David J ^a   Wang, Fei Lan ^a   Rodriguez Rojas, Ana Maria ^a   Wu, Zining ^a   Trice, Wen J ^a   Hoffman, Sandra J ^a   Votta, Bartholomew ^a   Stroup, George B ^a   Kumar, Sanjay ^a   Nuttall, Mark E ^a  

^a GLAXOSMITHKLINE   (United States)

Author keywords

Adipocyte; Bone marrow; Osteoporosis; Osteoprogenitor; Parathyroid hormone

Indexed keywords

2 (2 AMINO 3 METHOXYPHENYL)CHROMONE; ADENYLATE CYCLASE ACTIVATOR; AH 3960; ALKALINE PHOSPHATASE; BIOLOGICAL MARKER; CYCLIC AMP; CYCLIC AMP DEPENDENT PROTEIN KINASE INHIBITOR; DEXAMETHASONE; FORSKOLIN; GLYCEROL 3 PHOSPHATE DEHYDROGENASE; HORMONE RECEPTOR STIMULATING AGENT; INSULIN; ISOBUTYLMETHYLXANTHINE; LIPOPROTEIN LIPASE; MESSENGER RNA; MITOGEN ACTIVATED PROTEIN KINASE INHIBITOR; N [2 (4 BROMOCINNAMYLAMINO)ETHYL] 5 ISOQUINOLINESULFONAMIDE; PARATHYROID HORMONE; PARATHYROID HORMONE RECEPTOR 1; PARATHYROID HORMONE[1-34]; PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR GAMMA; TROGLITAZONE;

ADIPOCYTE; ADIPOGENESIS; ARTICLE; BONE MARROW CELL; CALCIUM SIGNALING; CELL COUNT; CELL CULTURE; CELL DIFFERENTIATION; CELL LINEAGE; CELL STRUCTURE; CELL VACUOLE; CONTROLLED STUDY; DRUG INTERMITTENT THERAPY; EMBRYO; ENZYME ACTIVITY; HORMONAL THERAPY; HUMAN; HUMAN CELL; MESENCHYMAL STEM CELL; OSTEOBLAST; PROTEIN EXPRESSION; SIGNAL TRANSDUCTION; STAINING; STROMA CELL;

ADENYLATE CYCLASE; ADIPOCYTES; ALKALINE PHOSPHATASE; BASE SEQUENCE; BONE MARROW CELLS; CELL DIFFERENTIATION; CELL LINE; CYCLIC AMP; DNA PRIMERS; GENE EXPRESSION; GENETIC MARKERS; GLYCEROLPHOSPHATE DEHYDROGENASE; HUMANS; LIPID METABOLISM; MESENCHYMAL STEM CELLS; OSTEOBLASTS; RECEPTOR, PARATHYROID HORMONE, TYPE 1; STROMAL CELLS; TERIPARATIDE;

EID: 34248506892     PISSN: 87563282     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.bone.2006.06.010     Document Type: Article

References (50)

1. Hock J.M., and Gera I. Effects of continuous and intermittent administration and inhibition of resorption on the anabolic response of bone to parathyroid hormone. J. Bone Miner. Res. 7 (1992) 65-72
2. Rubin M.R., Cosman F., Lindsay R., and Bilezikian J.P. The anabolic effect of parathyroid hormone. Osteoporos. Int. 13 (2002) 267-277
3. Neer R.M., Arnaud C.D., Zanchetta J.R., Prince R., Gaich G.A., Reginster J.-Y., et al. Effect of parathyroid hormone (1-34) on fractures and bone mineral density in postmenopausal women with osteoporosis. N. Engl. J. Med. 344 (2001) 1434-1441
4. Ma Y.L., Cain R.L., Halladay D.L., Yang X., Zeng Q., Miles R.R., et al. Catabolic effects of continuous human PTH(1-38) in vivo is associated with sustained stimulation of RANKL and inhibition of osteoprotegerin and gene-associated bone formation. Endocrinology 142 (2001) 4047-4054
5. Locklin R.M., Khosla S., Turner R.T., and Riggs B.L. Mediators of the biphasic responses of bone to intermittent and continuously administered parathyroid hormone. J. Cell. Biochem. 89 (2003) 180-190
6. Meng X.W., Liang X.G., Birchman R., Wu D.D., Dempster D.W., Lindsay R., et al. Temporal expression of the anabolic action of PTH in cancellous bone of ovariectomized rats. J. Bone Miner. Res. 11 (1996) 421-429
7. Dobnig H., and Turner R.T. Evidence that intermittent treatment with parathyroid hormone increases bone formation in adult rats by activation of bone lining cells. Endocrinology 136 (1995) 3632-3638
8. Nishida S., Yamagguchi A., Tanizawa T., Endo N., Mashiba T., Uchiyama Y., et al. Increased bone formation by intermittent parathyroid hormone administration is due to the stimulation of proliferation and differentiation of osteoprogenitor cells in bone marrow. Bone 15 (1994) 717-723
9. Kostenuik P.J., Harris J., Halloran B.P., Turner R.T., Morey-Holton E.R., and Bikle D.D. Skeletal unloading causes resistance of osteoprogenitor cells to parathyroid hormone and to insulin-like growth factor-1. J. Bone Miner. Res. 14 (1999) 21-31
10. Knopp E., Troiano N., Bouxsein M., Sun B.-H., Lostritto K., Gundberg C., et al. The effect of aging on the skeletal response to intermittent treatment with parathyroid hormone. Endocrinology 146 (2005) 1983-1990
11. Jilka R.L., Weinstein R.S., Bellido T., Roberson P., Parfitt A.M., and Manolagas S.C. Increased bone formation by prevention of osteoblast apoptosis with parathyroid hormone. J. Clin. Invest. 104 (1999) 439-446
12. Bellido T., Ali A.A., Plotkin L.I., Fu Q., Gubrij I., Roberson P.K., et al. Proteasomal degradation of Runx2 shortens parathyroid hormone-induced anti-apoptotic signaling in osteoblasts. J. Biol. Chem. 278 (2003) 50259-50272
13. Stanislaus D., Yang X., Liang J.D., Wolfe J., Cain R.L., Onyia J.E., et al. In vivo regulation of apoptosis in metaphyseal trabecular bone of young rats by synthetic human parathyroid hormone (1-34) fragment. Bone 27 (2000) 209-218
14. Chen H.-L., Demiralp B., Schneider A., Koh A.J., Silve C., Wang C.-Y., et al. Parathyroid hormone and parathyroid hormone-related protein exert both pro- and anti-apoptotic effects in mesenchymal cells. J. Biol. Chem. 277 (2002) 19374-19381
15. Aubin J.E., and Triffitt J.T. Mesenchymal stem cells and osteoblast differentiation. In: Bilezikian J.P., Raisz L.G., and Rodan G.A. (Eds). Principles of Bone Biology. 2nd ed. (2002), Academic Press 59-81
16. Beresford J.N., Bennett J.H., Devlin C., Leboy P.S., and Owen M.E. Evidence for an inverse relationship between the differentiation of adipocytic and osteogenic cells in rat marrow stromal cell cultures. J. Cell Sci. 102 (1992) 341-351
17. Spinella-Jaegle S., Rawadi G., Kawai S., Faucheu C., Mollat P., Courtois B., et al. Sonic hedgehog increases the commitment of pluripotent mesenchymal cells into the osteoblastic lineage and abolishes adipocytic differentiation. J. Cell Sci. 114 (2001) 2085-2094
18. Jaiswal R.K., Jaiswal N., Bruder S.P., Mbvalaviele G., Marshak D.R., and Pittenger M.F. Adult human mesenchymal stem cell differentiation to the osteogenic or adipogenic lineage is regulated by mitogen-activated protein kinase. J. Biol. Chem. 275 (2000) 9645-9652
19. Wronski T.J., Smith J.M., and Jee W.S.S. Variations in mineral apposition rate of trabecular bone within the Beagle skeleton. Calcif. Tissue Int. 33 (1981) 583-586
20. Sabatakos G., Sims N.A., Chen J., Aoki K., Kelz M.B., Amling M., et al. Overexpression of ΔFosB transcription factor(s) increases bone formation and inhibits adipogenesis. Nat. Med. 6 (2000) 985-990
21. Akune T., Ohba S., Kamekura S., Yamaguchi M., Chung U., Kubota N., et al. PPARγ insufficiency enhances osteogenesis through osteoblast formation from bone marrow progenitors. J. Clin. Invest. 113 (2004) 846-855
22. Meunier P.J., Aaron J., Edouard C., and Vignon G. Osteoporosis and the replacement of cell populations of the marrow by adipose tissue. Clin. Orthop. Relat. Res. 80 (1971) 147-154
23. Burkhardt R., Kettner G., Bohm W., Schmidmeier M., Schlag R., Frisch B., et al. Changes in trabecular bone, hematopoiesis and bone marrow vessels in aplastic anemia, primary osteoporosis, and old age: a comparative histomorphometric study. Bone 8 (1987) 157-164
24. Justesen J., Stenderup K., Ebbesen E.N., Mosekilde L., Steiniche T., and Kassem M. Adipocyte tissue volume in bone marrow is increased with aging and in patients with osteoporosis. Biogerontology 2 (2001) 165-171
25. Nuttall M.E., and Gimble J.M. Controlling the balance between osteo-blastogenesis and adipogenesis and consequent therapeutic implications. Curr. Opin. Pharmacol. 4 (2004) 290-294
26. Chan G.K., Deckelbaum R.A., Bolivar I., Goltzman D., and Karaplis A.C. PTHrP inhibits adipocyte differentiation by down-regulating PPARγ activity via a MAPK-dependent pathway. Endocrinology 142 (2001) 4900-4909
27. Chan G.K., Miao D., Deckelbaum R., Bolivar I., Karaplis A., and Goltzman D. Parathyroid hormone-related peptide interacts with bone morphogenetic protein 2 to increase osteoblastogenesis and decrease adipogenesis in pluripotent C3H10T1/2 mesenchymal cells. Endocrinology 144 (2003) 5511-5520
28. Amizuka N., Karaplis A.C., Henderson J.E., Warshawsky H., Lipman M.L., Matsuki Y., et al. Haploinsufficiency of parathyroid hormone-related peptide (PTHrP) results in abnormal postnatal bone development. Dev. Biol. 175 (1996) 166-176
29. Sato M., Westmore M., Ma Y.L., Schmidt A., Zeng Q.Q., Glass E.V., et al. Teriparatide [PTH(1-34)] strengthens the proximal femur of ovariectomized nonhuman primates despite increasing porosity. J. Bone Miner. Res. 19 (2004) 623-629
30. Dobnig H., and Turner R.T. The effects of programmed administration of human parathyroid hormone fragment (1-34) on bone histomorphometry and serum chemistry in rats. Endocrinology 138 (1997) 4607-4612
31. Frolik C.A., Black E.C., Cain R.L., Satterwhite J.H., Brown-Augsburger P.L., Sato M., et al. Anabolic and catabolic bone effects of human parathyroid hormone (1-34) are predicted by duration of hormone exposure. Bone 33 (2003) 372-379
32. Rickard D.J., Hofbauer L.C., Bonde S.K., Gori F., Spelsberg T.C., and Riggs B.L. Bone morphogenetic protein-6 production in human osteoblastic cell lines: selective regulation by estrogen. J. Clin. Invest. 101 (1998) 413-422
33. Xiao Z.S., Thomas R., Hinson T.K., and Quarles L.D. Genomic structure and isoform expression of the mouse, rat and human Cbfa1/Osf2 transcription factor. Gene 214 (1998) 187-197
34. Fajas L., Auboeuf D., Raspe E., Schoonjans K., Lefebvre A.-M., Saladin R., et al. The organization, promoter analysis, and expression of the human PPARγ gene. J. Biol. Chem. 272 (1997) 18779-18789
35. Wise L.S., and Green H. Participation of one isozyme of cytosolic glycerophosphate dehydrogenase in the adipose conversion of 3T3 cells. J. Biol. Chem. 254 (1979) 273-275
36. Gardella T.J., and Juppner H. Molecular properties of the PTH/PTHrP receptor. Trends Endocrinol. Metab. 12 (2001) 210-217
37. Guo J., Iida-Klein A., Huang X., Abou-Samra A.B., Segre G.V., and Bringhurst F.R. Parathyroid hormone (PTH)/PTH-related peptide receptor density modulates activation of phospholipase C and phosphate transport by PTH in LLC-PK1 cells. Endocrinology 136 (1995) 3884-3891
38. Leboy P.S., Beresford J.N., Devlin C., and Owen M.E. Dexamethasone induction of osteoblast mRNAs in rat marrow stromal cell cultures. J. Cell. Physiol. 146 (1991) 370-378
39. Rickard D.J., Kassem M., Hefferan T.E., Sarkar G., Spelsberg T.C., and Riggs B.L. Isolation and characterization of osteoblast precursor cells from human bone marrow. J. Bone Miner. Res. 11 (1996) 312-324
40. Ishizuya T., Yokose S., Hori M., Noda T., Suda T., Yoshiki S., et al. Parathyroid hormone exerts disparate effects on osteoblast differentiation depending on exposure time in rat osteoblastic cells. J. Clin. Invest. 99 (1997) 2961-2970
41. Wang Y.-H., Liu Y., Buhl K., and Rowe D.W. Comparison of the action of transient and continuous PTH on primary osteoblast cultures expressing differentiation stage-specific GFP. J. Bone Miner. Res. 20 (2005) 5-14
42. Lecka-Czernik B., Gubrij I., Moerman E.J., Kajkenova O., Lipschitz D.A., Manolagas S.C., et al. Inhibition of Osf2/Cbfa1 expression and terminal osteoblast differentiation by PPARγ2. J. Cell. Biochem. 74 (1999) 357-371
43. Khan E., and Abu-Amer Y. Activation of peroxisome proliferators-activated receptor-γ inhibits differentiation of pre-osteoblasts. J. Lab. Clin. Med. 142 (2003) 29-34
44. Whitfield J.F., Morley P., Langille R.M., and Willick G.E. Adenylyl cyclase-activating anabolic agents: parathyroid hormone and prostaglandins E. In: Whitfield J.F., and Morley P. (Eds). Anabolic Treatments for Osteoporosis (1998), CRC Press, Boca Raton, FL 110-149
45. Wang H., Watkins D.C., and Malbon C.C. Antisense oligodeoxynucleotides to Gs protein α-subunit sequence accelerate differentiation of fibroblasts to adipocytes. Nature 358 (1992) 334-337
46. Reusch J.E.B., Colton L.A., and Klemm D.J. CREB activation induces adipogenesis in 3T3-L1 cells. Mol. Cell. Biol. 20 (2000) 1008-1020
47. 2 to stimulate femoral trabecular bone growth in ovariectomized rats. Calcif. Tissue Int. 61 (1997) 322-326
48. Calvi L.M., Sims N.A., Hunzelman J.L., Knight M.C., Giovannetti A., Saxton J.M., et al. Activated parathyroid hormone/parathyroid hormone-related protein receptor in osteoblastic cells differentially affects cortical and trabecular bone. J. Clin. Invest. 107 (2001) 277-286
49. Kuznetsov S.A., Riminucci M., Ziran N., Tsutsui T.W., Corsi A., Calvi L., et al. The interplay of osteogenesis and hematopoiesis: expression of a constitutively active PTH/PTHrP receptor in osteogenic cells perturbs the establishment of hematopoiesis in bone and of skeletal stem cells in the bone marrow. J. Cell Biol. 167 (2004) 1113-1122
50. Ferrari S.L., and Bisello A. Cellular distribution of constitutively active mutant parathyroid hormone (PTH)/PTH-related protein receptors and regulation of cyclic adenosine 3′,5′-monophosphate signaling by β-arrestin2. Mol. Endocrinol. 15 (2001) 149-163